Range
0.43 - 0.46
Vol / Avg.
3.2M/9.7M
Div / Yield
-
52 Wk
0.26 - 1.57
Mkt Cap
67.6M
Payout Ratio
-
Open
0.45
P/E
-
EPS
-0.05
Shares
145.6M
Outstanding
145.6M
Total Float
145.6M
Benzinga - Jun 14, 2021, 4:06PM
Benzinga - May 20, 2021, 10:17AM
Benzinga - May 19, 2021, 5:03PM
Benzinga - May 19, 2021, 11:01AM
Benzinga - Apr 26, 2021, 8:14AM
Benzinga - Apr 20, 2021, 1:06PM
Benzinga - Apr 12, 2021, 10:18AM
Benzinga - Apr 12, 2021, 8:40AM
Benzinga - Apr 5, 2021, 8:04AM
Benzinga - Mar 16, 2021, 11:02AM
Benzinga - Mar 16, 2021, 9:02AM
load more
Sector: Health Care.Industry: Biotechnology
Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-09-09
REV
Q2 2021Est.ActualSurprise
EPS-0.040-0.040 0.0000
REV1.375M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ADXSAdvaxis-1.27%67.6M

Advaxis Frequently Asked Questions

Q

How do I buy Advaxis (ADXS) stock?

A

You can purchase shares of Advaxis (NASDAQ: ADXS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Advaxis's (ADXS) competitors?

A

Other companies in Advaxis’s space includes: Allena Pharmaceuticals (NASDAQ:ALNA), Biocept (NASDAQ:BIOC), Cellectar Biosciences (NASDAQ:CLRB), Monopar Therapeutics (NASDAQ:MNPR) and Addex Therapeutics (NASDAQ:ADXN).

Q

What is the target price for Advaxis (ADXS) stock?

A

The latest price target for Advaxis (NASDAQ: ADXS) was reported by HC Wainwright & Co. on December 18, 2018. The analyst firm set a price target for 0.00 expecting ADXS to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Advaxis (ADXS)?

A

The stock price for Advaxis (NASDAQ: ADXS) is $0.4639 last updated Today at 8:00:03 PM.

Q

Does Advaxis (ADXS) pay a dividend?

A

There are no upcoming dividends for Advaxis.

Q

When is Advaxis (NASDAQ:ADXS) reporting earnings?

A
Advaxis’s Q3 earnings are confirmed for after-market on September 9, 2021.
Q

Is Advaxis (ADXS) going to split?

A

There is no upcoming split for Advaxis.

Q

What sector and industry does Advaxis (ADXS) operate in?

A

Advaxis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.